Safety Study of JTT-302 in Subjects With Low HDL-C Levels
- First Posted Date
- 2008-09-09
- Last Posted Date
- 2013-02-04
- Lead Sponsor
- Akros Pharma Inc.
- Target Recruit Count
- 103
- Registration Number
- NCT00748852
Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-06-03
- Last Posted Date
- 2008-06-03
- Lead Sponsor
- Akros Pharma Inc.
- Target Recruit Count
- 92
- Registration Number
- NCT00688558
Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-06-03
- Last Posted Date
- 2008-06-03
- Lead Sponsor
- Akros Pharma Inc.
- Target Recruit Count
- 155
- Registration Number
- NCT00688896
Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-06-03
- Last Posted Date
- 2008-06-03
- Lead Sponsor
- Akros Pharma Inc.
- Target Recruit Count
- 105
- Registration Number
- NCT00689442
© Copyright 2024. All Rights Reserved by MedPath